TrialEuropean journal of clinical pharmacology2015

Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.

Mojca Jensterle et al.PubMed ↗Publisher ↗

No numbers read from the abstract.